Meduspace Acquires CP Cloud and LT3 for Medical Education Growth

Meduspace spa Società Benefit, a rapidly expanding platform in continuous medical education, has significantly enhanced its capabilities through the acquisition of two specialized entities: CP Cloud and LT3. This strategic move, orchestrated by investment firm Koinos Capital sgr through its Koinos Uno fund, marks a pivotal step in Meduspace's buy-and-build strategy aimed at consolidating the medical training sector.

The integration of CP Cloud, a Florence-based group with six subsidiaries including Euromediform and Regia Congressi, and LT3, a Como-based organizer of healthcare events, substantially broadens Meduspace's service portfolio. CP Cloud brings expertise in general medicine training and advanced clinical simulation via its VITS brand, alongside a competency certification body. LT3 contributes deep experience in organizing medical events, particularly in Pneumology, and offers end-to-end content production and digital communication services.

This dual acquisition propels the Meduspace group to an impressive aggregated annual revenue of approximately 54 million euros and expands its professional team to over 100 individuals. The transaction underscores Koinos Capital sgr's commitment to building a dominant force in medical education, following its initial platform launch in November 2025. The strategy aims to create a reference hub for medico-scientific training with a target revenue exceeding 100 million euros within the next two years.

The operational integration is expected to finalize shortly. Notably, the shareholders of both acquired companies have reinvested in the platform and will continue in their operational leadership roles, ensuring continuity and leveraging their established expertise. This reinvestment signals strong confidence in the future growth trajectory of the consolidated entity.

Meduspace's expanded offering now covers new therapeutic areas such as General Medicine and Pneumology, while incorporating advanced technological competencies like sophisticated clinical simulation. This diversification not only strengthens its position within the traditional continuous medical education (ECM) framework but also positions the company to explore opportunities beyond conventional boundaries. The company has already demonstrated significant reach, having trained over 180,000 healthcare professionals in 2025 alone.

This expansion aligns with the recent appointment of Sebastiano Di Guardo as Chief Executive Officer of Meduspace. With a proven track record in managing complex organizations, including previous roles at Ravenna Farmacie and Farmacap, Di Guardo is tasked with guiding the platform's ambitious growth and integration plans. The strategic acquisitions were supported by extensive due diligence from EY (financial, tax, payroll, ESG) and legal counsel from Simmons & Simmons, with compliance due diligence provided by S. Di Sabatino.